PT  - JOURNAL ARTICLE
AU  - McCarthy, Caroline
AU  - Moynagh, Patrick
AU  - Mannion, Áine
AU  - Wei, Ashely
AU  - Clyne, Barbara
AU  - Moriarty, Frank
TI  - Effectiveness of interactive dashboards to optimise prescribing in primary care: A systematic review
AID  - 10.1101/2024.08.22.24312420
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.08.22.24312420
4099  - http://medrxiv.org/content/early/2024/08/22/2024.08.22.24312420.short
4100  - http://medrxiv.org/content/early/2024/08/22/2024.08.22.24312420.full
AB  - Background Rising levels of both high-risk and low-value prescribing have the potential for adverse effects on patients, healthcare systems and society. It is thus necessary to develop effective and cost-effective interventions to support safe, effective and cost-effective prescribing. Advancements in technology, including machine learning coupled with the vast amounts of routine prescribing data available in primary care have supported the development of novel approaches to provide prescribers with ongoing and comparative prescribing data feedback. This systematic review aimed to explore the characteristics of interactive dashboard interventions in primary care that provide visual and longitudinal feedback on prescription data and to explore the effect of these interventions on prescribing-related outcome measures.Methods and Findings This systematic review was registered prospectively and reported in line with PRISMA guidelines. Multiple databases and grey literature were searched in November 2023 to identify interventional studies, including quasi-experimental designs that explored the effect of interactive dashboards on prescribing-related outcomes in primary care. Identified records were assessed for inclusion and data extraction and risk of bias assessment were completed by two independent researchers. Interventions characteristics and effects were described narratively. A meta-analysis using a random-effects model was performed where at least two studies were comparable in terms of participants, study design and outcomes. Twelve studies, reported across eleven different papers were included, eight randomised controlled trials, one controlled before and after study and three interrupted time series analyses. Nine papers were assessed to be of low risk of bias. Six studies reported a significant effect on prescribing-related outcomes, with an effect seen more often for studies focusing on potentially inappropriate or high-risk prescribing (four out of six studies). Two of the six studies that focused on antibiotic prescribing demonstrated a significant effect. A meta-analysis of three RCTs involving 406 general practices and 337,963 patients demonstrated the overall odds of having at least one potentially inappropriate prescription was 0.87 (95% CI 0.81 to 0.93 I2 =0.0%) in the intervention compared to control group.Conclusion Interactive dashboards have the potential to support safe and effective prescribing in primary care. To support their implementation, it is essential to establish the necessary data infrastructure within primary cares systems. This encompasses electronic health records (EHR) systems, data integration tools, analytics platforms, and compliance with data privacy regulations, all working together to facilitate the efficient use of data for improving prescribing and ultimately patient care.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocolshttps://hrbopenresearch.org/articles/7-44#:~:text=Interactive%20dashboards%20have%20demonstrated%20varied,and%2For%20behavioural%20components37.Funding StatementCMC is funded by a HRB post-doctoral Clinician Scientist Fellowship award (CSF- 2023-012) https://www.hrb.ie/funding/. PM is funded by an ICGP Post CSCST Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No new primary data were collected for this study, as the review synthesises publicly available data from published studies. All data generated or analysed during this study are included in this published article and its supplementary information files.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscriptNo new primary data were collected for this study, as the review synthesises publicly available data from published studies. All data generated or analysed during this study are included in this published article and its supplementary information files. This includes the search strategies used for each database, details of the included studies, and any additional data extracted during the review process. The study protocol is available as an open-access publication and can be accessed directly at https://hrbopenresearch.org/articles/7-44.PIPpotentially inappropriate prescribingEHRelectronic healthcare recordsRCTrandomised controlled trialITSAinterrupted time series analysisCBAcontrolled before and after studyEPOCEffective Practice and Organisation of CareTIDieRTemplate for Intervention Description and ReplicationAbxantibioticSABAshort acting beta agonist inhalerLABAlong acting beta agonist inhalerNSAIDnon-steroidal anti-inflammatory drugeGFRestimated glomerular filtration rateCKDchronic kidney diseaseCVDcardiovascular diseaseCCGclinical commissioning groupNICENational Institute for Clinical ExcellenceRTIrespiratory tract infectionCDSSclinical decision support-systemARRabsolute risk reductionORodds ratioDDDdefined daily dosageCIconfidence intervalRPrisky prescribingAFatrial fibrillation